TTM Technologies Form 4: 5.9K-share RSU award to business unit president
Rhea-AI Filing Summary
TTM Technologies Inc. (TTMI) filed a Form 4 on 25 Jun 2025 reporting an equity award to insider Anthony Joseph Sandeen, President of the company’s AMI&I Business Unit. On 24 Jun 2025, Sandeen received 5,893 restricted stock units (RSUs) at a cost of $0.00 per unit under TTMI’s long-term incentive plan.
Each RSU converts into one share of common stock. Vesting occurs in three equal tranches on the first, second and third anniversaries of the grant date, with share delivery within 30 days of 24 June each year. After the grant, Sandeen’s direct beneficial ownership rises to 43,442 shares. No shares were sold or otherwise disposed of, and no derivative transactions beyond the RSU grant were reported.
The transaction is a routine component of executive compensation aimed at retaining a key business unit leader and aligning management with shareholder value creation. Given TTMI’s multi-million-share float, the 5,893-share award is immaterial to dilution, but it reinforces the company’s commitment to equity-based incentives for senior management.
Positive
- Equity grant strengthens management–shareholder alignment
- Vesting over three years promotes executive retention and long-term focus
Negative
- Incremental dilution, albeit extremely small, adds to share count
Insights
TL;DR: Minor RSU grant to TTMI officer; negligible dilution, standard retention tool—overall neutral for valuation.
The 5,893-share RSU award represents a fraction of a basis point of TTMI’s outstanding shares, so earnings per share impact is de minimis. While the grant modestly increases insider ownership to 43,442 shares, it does not signal meaningful new information on operating performance or capital allocation. Investors may view the award positively for alignment but should not expect a price reaction.
TL;DR: Standard three-year vesting RSU structure supports retention; no governance red flags detected.
The filing shows typical Section 16 compliance and a well-structured vesting schedule that promotes executive continuity. No accelerated vesting, option repricing, or 10b5-1 plan designation is present, suggesting ordinary-course compensation. From a governance standpoint the grant is routine and does not materially alter control dynamics.